Spyre Therapeutics, Inc. (SYRE)

44.18 +0.97 (+2.24%) USD  |  NASDAQ  |  Feb 23, 16:00
44.21 +0.03 (+0.07%) After-Hours: 19:59
More

Spyre Therapeutics Annual EBITDA Margin Estimates

Annual EBITDA Margin Estimates Chart

View Annual EBITDA Margin Estimates for SYRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EBITDA Margin Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual EBITDA Margin Estimates Range, Past 5 Years

View Annual EBITDA Margin Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EBITDA Margin Estimates Benchmarks

View Annual EBITDA Margin Estimates Benchmarks
Start Trial
PTC Therapeutics, Inc. Upgrade
Tandem Diabetes Care, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. --